These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 14982847

  • 1. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells.
    Mitchell D, Rodgers K, Hanly J, McMahon B, Brady HR, Martin F, Godson C.
    Am J Pathol; 2004 Mar; 164(3):937-46. PubMed ID: 14982847
    [Abstract] [Full Text] [Related]

  • 2. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
    Wu SH, Lu C, Dong L, Zhou GP, He ZG, Chen ZQ.
    Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells.
    Zou L, Wang W, Xu Z, Zhang N, Jiang T.
    Int J Mol Med; 2012 Aug; 30(2):409-16. PubMed ID: 22614447
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
    Terada Y, Okado T, Inoshita S, Hanada S, Kuwahara M, Sasaki S, Yamamoto T, Marumo F.
    Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):1-10. PubMed ID: 15950964
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB.
    Kidney Int; 1997 Apr 04; 51(4):1228-36. PubMed ID: 9083291
    [Abstract] [Full Text] [Related]

  • 9. Akt serine threonine kinase regulates platelet-derived growth factor-induced DNA synthesis in glomerular mesangial cells: regulation of c-fos AND p27(kip1) gene expression.
    Choudhury GG.
    J Biol Chem; 2001 Sep 21; 276(38):35636-43. PubMed ID: 11470779
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.
    Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ.
    Kidney Int; 1997 Apr 21; 51(4):1088-99. PubMed ID: 9083274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of proteasomes in T cell activation and proliferation.
    Wang X, Luo H, Chen H, Duguid W, Wu J.
    J Immunol; 1998 Jan 15; 160(2):788-801. PubMed ID: 9551914
    [Abstract] [Full Text] [Related]

  • 14. Lovastatin inhibits mesangial cell proliferation via p27Kip1.
    Terada Y, Inoshita S, Nakashima O, Yamada T, Kuwahara M, Sasaki S, Marumo F.
    J Am Soc Nephrol; 1998 Dec 15; 9(12):2235-43. PubMed ID: 9848777
    [Abstract] [Full Text] [Related]

  • 15. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE.
    Oncogene; 1998 Aug 06; 17(5):631-41. PubMed ID: 9704929
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL.
    Cancer Res; 2001 Sep 01; 61(17):6583-91. PubMed ID: 11522658
    [Abstract] [Full Text] [Related]

  • 20. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.